Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation

L Brabenec, J Mekyska, Z Galaz, I Rektorova - Journal of neural …, 2017 - Springer
Hypokinetic dysarthria (HD) occurs in 90% of Parkinson's disease (PD) patients. It manifests
specifically in the areas of articulation, phonation, prosody, speech fluency, and faciokinesis …

Social symptoms of Parkinson's disease

MTM Prenger, R Madray, K Van Hedger… - Parkinson's …, 2020 - Wiley Online Library
Parkinson's disease (PD) is typically well recognized by its characteristic motor symptoms
(eg, bradykinesia, rigidity, and tremor). The cognitive symptoms of PD are increasingly being …

Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)

L Ramig, A Halpern, J Spielman, C Fox… - Movement …, 2018 - Wiley Online Library
Background As many as 89% of people with Parkinson's disease (PD) develop speech
disorders. Objectives This randomized controlled trial evaluated two speech treatments for …

Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease

J Rusz, R Cmejla, H Ruzickova… - The journal of the …, 2011 - pubs.aip.org
An assessment of vocal impairment is presented for separating healthy people from persons
with early untreated Parkinson's disease (PD). This study's main purpose was to (a) …

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

MS Okun, BV Gallo, G Mandybur, J Jagid… - The Lancet …, 2012 - thelancet.com
Background The effects of constant-current deep brain stimulation (DBS) have not been
studied in controlled trials in patients with Parkinson's disease. We aimed to assess the …

Speech treatment for Parkinson's disease

LO Ramig, C Fox, S Sapir - Expert review of neurotherapeutics, 2008 - Taylor & Francis
Researchers estimate that 89% of people with Parkinson's disease (PD) have speech and
voice disorders including disorders of laryngeal, respiratory and articulatory function …

Speech and swallowing disorders in Parkinson disease

S Sapir, L Ramig, C Fox - … opinion in otolaryngology & head and …, 2008 - journals.lww.com
Speech and swallowing disorders in Parkinson disease : Current Opinion in Otolaryngology &
Head and Neck Surgery Speech and swallowing disorders in Parkinson disease : Current …

Subthalamic Nucleus Versus Globus Pallidus I nternus Deep Brain Stimulation: Translating the Rematch Into Clinical Practice

NR Williams, KD Foote, MS Okun - Movement disorders clinical …, 2014 - Wiley Online Library
When formulating a DBS treatment plan for a patient with Parkinson's disease (PD), two
critical questions should be addressed:(1) Which brain target should be chosen to optimize …

Clinical and quality of life outcomes of speech treatment for Parkinson's disease delivered to the home via telerehabilitation: A noninferiority randomized controlled …

DG Theodoros, AJ Hill, TG Russell - American Journal of Speech-Language …, 2016 - ASHA
Purpose This study investigated the noninferiority and validity of an intensive speech
treatment for people with Parkinson's disease (PD) delivered via telerehabilitation to the …

Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation

T Tsuboi, H Watanabe, Y Tanaka, R Ohdake… - Journal of Neurology …, 2015 - jnnp.bmj.com
Objectives To elucidate the phenotypes and pathophysiology of speech and voice disorders
in Parkinson's disease (PD) with subthalamic nucleus deep brain stimulation (STN-DBS) …